Physician profile
Robin R Johnson
NPI 1891020889
$1,001.82
in general payments reported to CMS, 2019-2025
20 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Registered Nurse provider received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $321 · 2023: $177 · 2024: $151 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $282.06 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $98.18 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $95.70 | 2021-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Abbvie INC. | $77.21 | 2022-2025 | |
| Lilly USA, LLC | $69.85 | 2021-2023 | Emgality, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.82 | 2021-2024 | Jardiance |
| Amgen INC. | $42.18 | 2022-2023 | Repatha, Otezla |
| Genentech USA, INC. | $40.42 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.37 | 2022 | |
| Glaxosmithkline, LLC. | $31.65 | 2023-2025 | Trelegy Ellipta |
| Eisai INC. | $22.07 | 2023 | |
| Sumitomo Pharma America, INC. | $19.88 | 2023 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $19.50 | 2021 | |
| Nabriva Therapeutics, Plc | $19.30 | 2022 | |
| Sunovion Pharmaceuticals INC. | $17.78 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $14.74 | 2022 | |
| Amarin Pharma, INC. | $14.24 | 2021 | |
| Evofem Biosciences, INC. | $14.09 | 2021 | |
| Exact Sciences Corporation | $13.88 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.